Researchers demonstrate in both the laboratory and in animal models why the D614G variant was able to gain the upper hand over the original SARS-CoV-2 virus
These reagents can be used by researchers to evaluate the efficacy of the antibodies and identify targets for development of improved therapeutic drugs and vaccines
Researchers analyzed daily low temperatures and infection rates in 50 Northern Hemisphere countries to quantify their effect on SARS-CoV-2 transmission